Clinical Trial Update: A Study of BEN301 Injection in theTreatment of Autoimmune Diseases [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 study of BEN301 Injection for multiple autoimmune diseases is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Inflammatory Myopathies
• Rheumatoid Arthritis
• Sjögren Syndrome
• Systemic Sclerosis

Drugs mentioned

• BEN301 Injection

Snippet

Sponsor: RenJi Hospital | Conditions: Systemic Sclerosis (SSc), Rheumatoid Arthritis (RA) | EARLY_Phase 1 | Status: NOT_YET_RECRUITING